VT News
Kim Mi-kyung

Kim Mi-kyung

Ask VT AI
View News Summary
  • DaVita's Q3 earnings miss expectations, with lower dialysis treatments and higher costs, leading to narrowed guidance and stock decline.
  • Trump's surgeon general nominee delays confirmation hearing after going into labor, prolonging vacancy in the role.
  • Novo Nordisk makes a bold $9B bid to acquire Metsera, a U.S. biotech firm, in a bid to outpace Pfizer's existing $4.9B deal and regain leadership in the competitive obesity drug market.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • DaVita's Q3 earnings miss expectations, with lower dialysis treatments and higher costs, leading to narrowed guidance and stock decline.
  • Trump's surgeon general nominee delays confirmation hearing after going into labor, prolonging vacancy in the role.
  • Novo Nordisk makes a bold $9B bid to acquire Metsera, a U.S. biotech firm, in a bid to outpace Pfizer's existing $4.9B deal and regain leadership in the competitive obesity drug market.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Kim Mi-kyung

Top Topics

Trending in U.S.

World

Sport